First Risperdal Trial Ends With $2.5 Million Verdict Against J&J

First Risperdal Trial Ends With $2.5 Million Verdict Against J&J

A Philadelphia jury returned a $2.5 million verdict against healthcare giant Johnson & Johnson for a 20-year-old autistic man from Alabama who allegedly developed large breasts as a teenager while prescribed the antipsychotic medication Risperdal. The lawsuit charged that Johnson & Johnson failed to warn consumers of the distressing side effects that Risperdal causes, concealing from officials the dangerous and defective risks involved when taking the prescribed medication.

[Read more…]